Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
<p>Warfarin is commonly used in thromboembolic conditions. Warfarin interruption represents a significant challenge in pre-operative warfarin management as it is associated with major consequences. Genetics polymorphism demonstrated to be a significant predictor of the required days of warfari...
محفوظ في:
| المؤلف الرئيسي: | Islam Eljilany (14151588) (author) |
|---|---|
| مؤلفون آخرون: | Hazem Elewa (3592601) (author), Daoud Al-Badriyeh (832403) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Cost-Benefit Analysis of Genotype-Guided Interruption Days in Warfarin Pre-Procedural Management
حسب: Islam, Eljilany
منشور في: (2022) -
Bridging vs Non-Bridging with Warfarin Peri-Procedural Management: Cost and Cost-Effectiveness Analyses
حسب: Islam Eljilany (14151588)
منشور في: (2021) -
The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
حسب: Islam Eljilany (14151588)
منشور في: (2021) -
Periprocedural Anticoagulation Management of Patients receiving Warfarin in Qatar: A Prospective Cohort Study
حسب: Islam Eljilany (14151588)
منشور في: (2021) -
Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey
حسب: Islam Eljilany (14151588)
منشور في: (2022)